Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietrich Häfner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Translational Allergy|June 24, 2014
Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studiesDietrich Häfner, Viola Gödicke, Annemie Narkus
The Journal of Allergy and Clinical Immunology|March 8, 2011
Recombinant allergens for specific immunotherapyOliver Cromwell, Dietrich Häfner, Andreas Nandy
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 28, 2003
Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS)Dietrich Häfner, Merdol Ibrahim, Lutz Wollin, et al.
Clinical and Translational Allergy|September 21, 2012
Prospective validation of the "rhino conjunctivitis allergy-control-SCORE©" (RC-ACS©)Dietrich Häfner, Kristian Reich, Ina Zschocke, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2003
Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactantRoger G Spragg, James F Lewis, Wilhelm Wurst, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonideMichael Stoeck, Richard Riedel, Günther Hochhaus, et al.
Chest|August 12, 2008
A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute)Friedemann J H Taut, Gerd Rippin, Peter Schenk, et al.
The New England Journal of Medicine|August 27, 2004
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndromeRoger G Spragg, James F Lewis, Hans-Dieter Walmrath, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Translational Allergy|June 24, 2014
Allergen specific immunotherapy has no influence on standard chemistry and hematology laboratory parameters in clinical studiesDietrich Häfner, Viola Gödicke, Annemie Narkus
The Journal of Allergy and Clinical Immunology|March 8, 2011
Recombinant allergens for specific immunotherapyOliver Cromwell, Dietrich Häfner, Andreas Nandy
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|August 28, 2003
Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS)Dietrich Häfner, Merdol Ibrahim, Lutz Wollin, et al.
Clinical and Translational Allergy|September 21, 2012
Prospective validation of the "rhino conjunctivitis allergy-control-SCORE©" (RC-ACS©)Dietrich Häfner, Kristian Reich, Ina Zschocke, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2003
Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactantRoger G Spragg, James F Lewis, Wilhelm Wurst, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonideMichael Stoeck, Richard Riedel, Günther Hochhaus, et al.
Chest|August 12, 2008
A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute)Friedemann J H Taut, Gerd Rippin, Peter Schenk, et al.
The New England Journal of Medicine|August 27, 2004
Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndromeRoger G Spragg, James F Lewis, Hans-Dieter Walmrath, et al.
Pageof 1